Understanding your role in detecting, reducing and preventing the development of antimicrobial resistance (AMR) is key to combating this growing threat. Once we realize how our actions can impact AMR, we can then take appropriate actions to stop and reduce its development and spread.
In 2015, the CRE strain of KPC (Klebsiella pneumonia carbapenemase) took the lives of seven patients at the National Institutes of Health Clinical Center near Washington, D.C. According to the CDC, the first reported CRE case occurred in a North Carolina Hospital in 2001, and since then, cases have been identified in 41 states.
Welcome to bioMérieux Connection, your source for learning and discussion of medical diagnostics and scientific news, advancements, important issues, and much more. Our team is dedicated to serving you the most relevant and pressing stories from leading experts in medicine, microbiology, and other scientific fields.